載入...
Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a new class of drugs that might have a potential beneficial effect on bone metabolism. Data on the effect of GLP-1 RAs and fracture risk are lacking. The aim of the present study was to investigate the association between the use of GLP-1 and...
Na minha lista:
| 發表在: | Calcif Tissue Int |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer US
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4598352/ https://ncbi.nlm.nih.gov/pubmed/26184119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-015-0037-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|